Comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 vs 3q26 Microduplication Syndrome C4755319
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Exogenous Maternal Derived Androgen and 3q26 Microduplication Syndrome for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
A condition caused when a pregnant person takes hormone medications containing androgens, affecting fetal development. The fetus has XX chromosomes. Stopping the offending agent is key, with specialist care for affected infants.
3q26 Microduplication Syndrome C4755319
A genetic condition involving extra genetic material at chromosome 3q26, which can cause developmental delays and other features depending on specific genes involved.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Variable
3q26 Microduplication Syndrome C4755319
0-null
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
severe
3q26 Microduplication Syndrome C4755319
moderate
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
Chronic
3q26 Microduplication Syndrome C4755319
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
No
3q26 Microduplication Syndrome C4755319
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
reproductive
3q26 Microduplication Syndrome C4755319
congenital
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
endocrine
3q26 Microduplication Syndrome C4755319
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-exogenous-maternal-derived-androgen-C5679874 and 3q26-microduplication-syndrome-C4755319 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3q26 Microduplication Syndrome C4755319 | Discriminating power |
|---|---|---|---|
| Genital development | Atypical genital development may occur in an XX fetus after androgen exposure. | Genital findings are not established from the supplied description. | Moderate |
| Neurodevelopment | Developmental delay is not described as a defining feature. | Developmental delay may occur, depending on genes involved. | Moderate |
| Exposure or genetic history | History centers on androgen-containing medication during pregnancy. | History centers on extra chromosomal material at 3q26. | High |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 when
Documented pregnancy exposure to androgen-containing medication
The supplied etiology is exogenous maternal androgen exposure in an XX fetus.
High
XX karyotype with atypical genital development
This pattern fits the described reproductive developmental condition, but other causes must be excluded.
Moderate
Need to stop an implicated medication
Stopping the offending agent is identified as key, with specialist infant care.
Moderate
Choose 3q26 Microduplication Syndrome C4755319 when
Chromosomal testing shows extra 3q26 material
The diagnosis depends on the described chromosomal duplication.
High
Developmental delay with congenital features
These features may prompt evaluation, but they are not specific.
Low
No relevant androgen exposure history
Absence of exposure makes the exogenous androgen mechanism less likely, without proving the duplication.
Moderate
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874 | 3q26 Microduplication Syndrome C4755319 | Interpretation |
|---|---|---|---|
| Karyotype | XX chromosomal sex is part of the condition. | Karyotype result is not specified in the source. | XX status supports the left description but does not establish causation. |
| Chromosomal microarray | No specific copy-number abnormality is described. | Extra material at 3q26 supports the syndrome. | A confirmed 3q26 duplication distinguishes the right condition. |
| Medication and endocrine review | Androgen-containing pregnancy medication is the key historical finding. | No characteristic medication exposure is described. | Exposure history supports the left mechanism but needs clinical correlation. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Exogenous Maternal Derived Androgen C5679874
- Outcome
- Long-term outcome is not established; specialist care is recommended.
- Factors
- Timing and nature of exposure and individual clinical findings may matter, but effects are not quantified.
3q26 Microduplication Syndrome C4755319
- Outcome
- Outcome is variable and not established from the supplied description.
- Factors
- Specific genes involved and developmental findings may influence course.
Time frame: Both may have chronic implications, but timelines are not established.
Etiology, confirmed test results, and individual clinical assessment should guide prognosis.
Complications comparison
| Complication | Presentation |
|---|---|
| Atypical genital development | May affect the XX fetus and require specialist assessment. Not established by the supplied description. Do not infer a specific genital phenotype without examination. |
| Developmental delay | Not established as a characteristic complication. May occur and vary with involved genes. Severity and functional impact are not quantified here. |
| Need for ongoing specialist care | Affected infants may need endocrine and reproductive specialist follow-up. Genetic and developmental follow-up may be appropriate. Care plans should be individualized; outcomes are not established. |
Patient education highlights
- HighDifferent causes
One condition is linked to pregnancy androgen exposure; the other is a chromosomal duplication.
- HighTesting limits
An abnormal finding or history is not itself a complete diagnosis and needs clinician review.
- MediumVariable features
Features and severity can vary, and exact prognosis is not established from these sources.